TY - JOUR
T1 - Proceedings of the 11th Annual Deep Brain Stimulation Think Tank
T2 - pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements
AU - Johnson, Kara A.
AU - Dosenbach, Nico U.F.
AU - Gordon, Evan M.
AU - Welle, Cristin G.
AU - Wilkins, Kevin B.
AU - Bronte-Stewart, Helen M.
AU - Voon, Valerie
AU - Morishita, Takashi
AU - Sakai, Yuki
AU - Merner, Amanda R.
AU - Lázaro-Muñoz, Gabriel
AU - Williamson, Theresa
AU - Horn, Andreas
AU - Gilron, Ro'ee
AU - O'Keeffe, Jonathan
AU - Gittis, Aryn H.
AU - Neumann, Wolf Julian
AU - Little, Simon
AU - Provenza, Nicole R.
AU - Sheth, Sameer A.
AU - Fasano, Alfonso
AU - Holt-Becker, Abbey B.
AU - Raike, Robert S.
AU - Moore, Lisa
AU - Pathak, Yagna J.
AU - Greene, David
AU - Marceglia, Sara
AU - Krinke, Lothar
AU - Tan, Huiling
AU - Bergman, Hagai
AU - Pötter-Nerger, Monika
AU - Sun, Bomin
AU - Cabrera, Laura Y.
AU - McIntyre, Cameron C.
AU - Harel, Noam
AU - Mayberg, Helen S.
AU - Krystal, Andrew D.
AU - Pouratian, Nader
AU - Starr, Philip A.
AU - Foote, Kelly D.
AU - Okun, Michael S.
AU - Wong, Joshua K.
N1 - Publisher Copyright:
Copyright © 2024 Johnson, Dosenbach, Gordon, Welle, Wilkins, Bronte-Stewart, Voon, Morishita, Sakai, Merner, Lázaro-Muñoz, Williamson, Horn, Gilron, O'Keeffe, Gittis, Neumann, Little, Provenza, Sheth, Fasano, Holt-Becker, Raike, Moore, Pathak, Greene, Marceglia, Krinke, Tan, Bergman, Pötter-Nerger, Sun, Cabrera, McIntyre, Harel, Mayberg, Krystal, Pouratian, Starr, Foote, Okun and Wong.
PY - 2024
Y1 - 2024
N2 - The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9–11, 2023 in Gainesville, Florida with the theme of “Pushing the Forefront of Neuromodulation”. The keynote speaker was Dr. Nico Dosenbach from Washington University in St. Louis, Missouri. He presented his research recently published in Nature inn a collaboration with Dr. Evan Gordon to identify and characterize the somato-cognitive action network (SCAN), which has redefined the motor homunculus and has led to new hypotheses about the integrative networks underpinning therapeutic DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers, and researchers (from industry and academia) can freely discuss current and emerging DBS technologies, as well as logistical and ethical issues facing the field. The group estimated that globally more than 263,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas: cutting-edge translational neuromodulation, cutting-edge physiology, advances in neuromodulation from Europe and Asia, neuroethical dilemmas, artificial intelligence and computational modeling, time scales in DBS for mood disorders, and advances in future neuromodulation devices.
AB - The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9–11, 2023 in Gainesville, Florida with the theme of “Pushing the Forefront of Neuromodulation”. The keynote speaker was Dr. Nico Dosenbach from Washington University in St. Louis, Missouri. He presented his research recently published in Nature inn a collaboration with Dr. Evan Gordon to identify and characterize the somato-cognitive action network (SCAN), which has redefined the motor homunculus and has led to new hypotheses about the integrative networks underpinning therapeutic DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers, and researchers (from industry and academia) can freely discuss current and emerging DBS technologies, as well as logistical and ethical issues facing the field. The group estimated that globally more than 263,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas: cutting-edge translational neuromodulation, cutting-edge physiology, advances in neuromodulation from Europe and Asia, neuroethical dilemmas, artificial intelligence and computational modeling, time scales in DBS for mood disorders, and advances in future neuromodulation devices.
KW - Parkinson's disease
KW - adaptive DBS
KW - artificial intelligence
KW - deep brain stimulation (DBS)
KW - epilepsy
KW - interventional psychiatry
KW - neuroethics
KW - optogenetics
UR - http://www.scopus.com/inward/record.url?scp=85186912919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186912919&partnerID=8YFLogxK
U2 - 10.3389/fnhum.2024.1320806
DO - 10.3389/fnhum.2024.1320806
M3 - Article
C2 - 38450221
AN - SCOPUS:85186912919
SN - 1662-5161
VL - 18
JO - Frontiers in Human Neuroscience
JF - Frontiers in Human Neuroscience
M1 - 1320806
ER -